期刊文献+

普罗帕酮与胺碘酮治疗心律失常的价值比较分析 被引量:2

Value of Propafenone and Amiodarone in the Treatment of Arrhythmia
下载PDF
导出
摘要 目的研究并比较普罗帕酮与胺碘酮治疗心律失常的临床效果及其对血清炎症因子的影响。方法选取2014年1月-2016年12月我院接收的90例心律失常患者作为研究对象,采取计算机单盲随机分组方法分为两组,每组45例,A组接受普罗帕酮治疗,B组接受胺碘酮治疗,比较两组总有效率、血清炎症因子指标、不良反应发生率。结果 A组的总有效率为82.22%,B组为95.56%,差异有统计学意义(P<0.05);A组的不良反应发生率为4.44%,B组为6.67%,差异无统计学意义(P>0.05)。干预前两组炎症指标CRP、IL-6相近,差异无统计学意义(P>0.05);干预后B组CRP、IL-6炎症因子水平(2.11±0.51)mg/L、(61.24±2.16)pg/ml低于A组(4.92±0.15)mg/L、(127.13±2.48)pg/ml,差异有统计学意义(P<0.05)。结论普罗帕酮、胺碘酮治疗心律失常均具有良好的安全性,但胺碘酮对心律失常更加有效,且其对血清炎症因子的抑制作用更加显著。 Objective To study and compare the clinical effects of propafenone and amiodarone on arrhythmia and their effects on serum inflammatory factors.Methods Totally 90 patients with arrhythmia received in our hospital from January 2014 to December 2016 were enrolled in this study.They were randomly divided into two groups(45 cases in each group),group A received propafenone treatment,and group B Group received amiodarone treatment,the total effective rate of two groups,serum inflammatory cytokines,the incidence of adverse reactions were compared.Results The total effective rate in group A was 82.22%,in group B was 95.56%,the difference was statistically significant(P<0.05).The incidence of adverse reactions in group A was 4.44%,while in group B was 6.67%,the difference was not statistically significant(P>0.05).The levels of inflammatory cytokines CRP and IL-6 in the two groups before intervention were similar(P>0.05).After intervention,the levels of CRP and IL-6 inflammatory cytokines in group B were(2.11±0.51)mg/L and(61.24±2.16)pg/ml,respectively In group A,(4.92±0.15)mg/L and(127.13±2.48)pg/ml,the difference was statistically significant(P<0.05).Conclusion Propafenone and amiodarone have good safety in the treatment of arrhythmia,but amiodarone is more effective on arrhythmia,and its inhibitory effect on serum inflammatory factor is more significant.
作者 胡琴兰 HU Qinlan(First Department of Rehabilitation Hospital,Jingmen City,Hubei Province,Jingmen Hubei 448000,China)
出处 《中国继续医学教育》 2018年第9期102-104,共3页 China Continuing Medical Education
关键词 心律失常 普罗帕酮 胺碘酮 血清炎症因子 arrhythmia propafenone amiodarone serum inflammatory factors
  • 相关文献

参考文献8

二级参考文献62

  • 1段晨初,谷疆蓉,甄丽娜,刘育.心律平与胺碘酮治疗心律失常疗效比较的Meta分析[J].中国生化药物杂志,2014,34(5):79-82. 被引量:47
  • 2龚发英,孙丽琴.心率变异性预测心律失常的临床价值研究[J].中国新医药,2004,3(7):48-49. 被引量:1
  • 3沈洪,郭继鸿.ACC/AHA/ESC的《室上性心律失常治疗指南》[J].中国危重病急救医学,2004,16(9):513-514. 被引量:13
  • 4蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:143
  • 5李创鹏,彭敏,刘培中.炙甘草汤对PTCA术后心律失常P选择素内皮素CRP影响临床研究[J].中医药学刊,2006,24(4):655-656. 被引量:12
  • 6Hirasawa Y, Nakagomi A, Kobyashi Y, et al. Sh0rt-term amioda- rone treatment attenuates the production of moncyte cytokines and ehemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventficulartachycardia. Cite J,2009,73 (4) :639 -646.
  • 7Saul JP, La Page MJ. Is it time to tell the emperor he has no clothes intravenous amiodarone for supraventricular arrhythmias in chil- dren. Circ Arrhythm Electrophysio1,2010,3 ( 2 ) : 115-117.
  • 8林元涛,徐艳.普罗帕酮与美托洛尔联用治疗小儿心律失常的临床疗效分析[J].医药前沿,2012,02(14):101-102.
  • 9Pablo A. Fernández,Ricardo Bonato,Jorge Galperin,Rubén A. Sánchez,Hugo A. Garro,Rafael Acunzo,Manuel Lago,Marcelo V. Elizari,Pablo A. Chiale.Intravenous amiodarone facilitates electrical cardioversion in patients with persistent atrial fibrillation pre-treated with oral amiodarone[J]. International Journal of Cardiology . 2011 (2)
  • 10McDonald M G,Au N T,Wittkowsky A K,Rettie A E.Warfarin-amiodarone drug-drug interactions: determination of [I](u)/K(I,u) for amiodarone and its plasma metabolites. Clinical Pharmacokinetics . 2012

共引文献216

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部